Pancreatic Cancer Research

ResearcherYokohama City UniversityActive in the last 2 years

Shuhei Nagashima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9862-7861; OpenAlex author ID A5065006734. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2021: 1 paper · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper

Papers 6

  1. Liposomal irinotecan plus fluorouracil/leucovorin in older patients with advanced pancreatic cancer: a single-center retrospective study. Co-author DOI 10.1007/s10147-023-02432-9↗
  2. FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational… Co-author DOI 10.1186/s12885-023-10654-3↗
  3. Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second-line treatment regimen for unresectable pancreatic cancer: A real-world analysi… Co-author DOI 10.1002/cam4.4512↗
  4. Nal-IRI/5-FU/LV versus modified FOLFIRINOX and FOLFIRI as second-line chemotherapy for unresectable pancreatic cancer: A single center retrospective study. Co-author DOI 10.1016/j.pan.2022.06.004↗
  5. Sarcopenia: Prognostic Value for Unresectable Pancreatic Ductal Adenocarcinoma Patients Treated With Gemcitabine Plus Nab-Paclitaxel. Co-author DOI 10.1097/mpa.0000000000001985↗
  6. Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer. Co-author DOI 10.1111/cas.15106↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Satoshi Kobayashi · 6 shared papers, 2021–2024 · strength 0.93
  2. Manabu Morimoto · 6 shared papers, 2021–2024 · strength 0.93
  3. Makoto Ueno · 6 shared papers, 2021–2024 · strength 0.93
  4. Shin Maeda · 4 shared papers, 2022–2024 · strength 0.66
  5. Shun Tezuka · 4 shared papers, 2021–2023 · strength 0.57
  6. Yuichiro Tozuka · 2 shared papers, 2023–2024 · strength 0.38
  7. Junji Furuse · 2 shared papers, 2023–2024 · strength 0.38
  8. Hiroyuki Asama · 2 shared papers, 2022 · strength 0.28
  9. Maeda Shin · 1 shared paper, 2022 · strength 0.15
  10. Hiromasa Ohira · 1 shared paper, 2022 · strength 0.15
  11. Yohei Miyagi · 1 shared paper, 2021 · strength 0.11
  12. Shiro Koizume · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.